Neuroone Medical Technologies (NMTC) Accumulated Depreciation & Amortization (2019 - 2026)
Neuroone Medical Technologies posted quarterly Accumulated Depreciation & Amortization of $913218.0 for Q1 2026, up 34.48% year-on-year from $679063.0 in Q1 2025, and up 6.34% on a QoQ basis from $858768.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) has 8 years of Accumulated Depreciation & Amortization data on file, last reported at $913218.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 34.48% year-over-year to $913218.0; the trailing twelve-month figure through Mar 2026 stood at $913218.0 (up 34.48% YoY), and the FY2025 full-year result was $798823.0, up 42.78% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $913218.0, up from $858768.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $540.0 billion in Q3 2022 and bottomed at $132586.0 in Q1 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $500912.0 (2024), against an average of $31.8 billion.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 599604180.19%; it then plunged 100.0% in 2023.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $216667.0 in 2022, then soared by 79.11% to $388062.0 in 2023, then soared by 59.51% to $619008.0 in 2024, then soared by 38.73% to $858768.0 in 2025, then gained by 6.34% to $913218.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $913218.0 (Q1 2026), $858768.0 (Q4 2025), and $798823.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 913,218.00 |
| Mar 31, 2026 | 913,218.00 |
| Dec 31, 2025 | 858,768.00 |
| Dec 31, 2025 | 858,768.00 |
| Sep 30, 2025 | 798,823.00 |
| Sep 30, 2025 | 798,823.00 |
| Jun 30, 2025 | 740,078.00 |
| Jun 30, 2025 | 740,078.00 |
| Mar 31, 2025 | 679,063.00 |
| Mar 31, 2025 | 679,063.00 |
| Dec 31, 2024 | 619,008.00 |
| Dec 31, 2024 | 619,008.00 |
| Sep 30, 2024 | 559,460.00 |
| Sep 30, 2024 | 559,460.00 |
| Jun 30, 2024 | 500,912.00 |
| Jun 30, 2024 | 500,912.00 |
| Mar 31, 2024 | 443,383.00 |
| Mar 31, 2024 | 443,383.00 |
| Dec 31, 2023 | 388,062.00 |
| Dec 31, 2023 | 388,062.00 |
| Sep 30, 2023 | 334,984.00 |
| Sep 30, 2023 | 334,984.00 |
| Jun 30, 2023 | 304,483.00 |
| Jun 30, 2023 | 304,483.00 |
| Mar 31, 2023 | 254,998.00 |
| Mar 31, 2023 | 254,998.00 |
| Dec 31, 2022 | 216,667.00 |
| Dec 31, 2022 | 216,667.00 |
| Sep 30, 2022 | 539.96 Bn |
| Sep 30, 2022 | 539.96 Bn |
| Jun 30, 2022 | 158,514.00 |
| Jun 30, 2022 | 158,514.00 |
| Mar 31, 2022 | 132,586.00 |
| Mar 31, 2022 | 132,586.00 |
| Dec 31, 2021 | 109,634.00 |
| Dec 31, 2021 | 109,634.00 |
| Sep 30, 2021 | 90,052.00 |
| Sep 30, 2021 | 90,052.00 |
| Jun 30, 2021 | 73,268.00 |
| Jun 30, 2021 | 73,268.00 |
| Mar 31, 2021 | 58,492.00 |
| Mar 31, 2021 | 58,492.00 |
| Dec 31, 2020 | 44,777.00 |
| Dec 31, 2020 | 44,777.00 |
| Sep 30, 2020 | 31,620.00 |
| Sep 30, 2020 | 31,620.00 |
| Jun 30, 2020 | 23,431.00 |
| Jun 30, 2020 | 23,431.00 |
| Mar 31, 2020 | 16,133.00 |
| Mar 31, 2020 | 16,133.00 |
| Dec 31, 2019 | 10,645.00 |
| Dec 31, 2019 | 10,645.00 |
| Sep 30, 2019 | 6,326.00 |
| Sep 30, 2019 | 6,326.00 |
| Jun 30, 2019 | 694.00 |
| Jun 30, 2019 | 694.00 |